STRO - SUTRO BIOPHARMA, INC.
34.58
3.030 8.762%
Share volume: 201,817
Last Updated: 04-20-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$31.55
3.03
0.10%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-13-2024 | 08-13-2024 | 11-13-2024 | 03-13-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | 03-23-2026 | |
| Assets | |||||||||
| Total Assets | 403.402 M | 489.043 M | 451.832 M | 387.207 M | 321.430 M | 262.355 M | 209.658 M | 173.830 M | |
| Current Assets | 354.582 M | 443.475 M | 405.779 M | 343.310 M | 287.409 M | 231.630 M | 182.113 M | 150.926 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 10.064 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 10.064 M | 335.204 M | 213.675 M | 126.591 M | 142.743 M | 141.106 M | 101.667 M | 83.298 M | |
| Total Receivables | 31.300 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 313.218 M | 90.788 M | 174.579 M | 190.304 M | 106.229 M | 64.025 M | 65.927 M | 58.130 M | |
| Total Non-current Assets | 48.820 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 20.630 M | 19.414 M | 18.997 M | 18.190 M | 16.798 M | 14.981 M | 13.346 M | 10.648 M | |
| Other Assets | 27.333 M | 26.154 M | 27.056 M | 25.707 M | 17.223 M | 15.744 M | 14.199 M | 12.256 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 403.402 M | 489.043 M | 451.832 M | 387.207 M | 321.430 M | 262.355 M | 209.658 M | 173.830 M | |
| Total liabilities | 305.378 M | 336.867 M | 340.612 M | 342.606 M | 347.241 M | 294.466 M | 296.926 M | 306.282 M | |
| Total current liabilities | 79.509 M | 129.985 M | 131.291 M | 131.893 M | 133.046 M | 74.246 M | 71.895 M | 75.133 M | |
| Accounts Payable | 7.511 M | 6.086 M | 6.216 M | 10.475 M | 8.180 M | 4.308 M | 7.034 M | 7.565 M | |
| Other liabilities | 204.472 M | 185.192 M | 191.322 M | 198.177 M | 205.627 M | 213.314 M | 221.273 M | 229.121 M | |
| Current long term debt | 6.673 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 21.397 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 204.472 M | 185.192 M | 191.322 M | 198.177 M | 205.627 M | 213.314 M | 221.273 M | 229.121 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 98.024 M | 152.176 M | 111.220 M | 44.601 M | -25.811 M | -32.111 M | -87.268 M | -132.452 M | |
| Common stock | 61.458 M | 817.978 M | 825.540 M | 831.431 M | 837.035 M | 842.238 M | 843.892 M | 845.484 M | |
| Retained earnings | -617.621 M | -665.639 M | -714.426 M | -786.869 M | -862.837 M | -874.336 M | -931.193 M | -977.955 M |